Novel Drug Approvals for 2023
In 2023, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) hit a significant milestone,
Peptides – unique medicines
In contrast to proteins and small molecules, peptides represent a unique class of pharmaceutical compounds that are biochemically and therapeutically
Everything you want to know about the progress of biomedicine in 2023 is here
「TL;DR」: 2023 will be a challenging year for most biopharmaceutical practitioners. This year, the capital market has performed hard and
Continue readingEverything you want to know about the progress of biomedicine in 2023 is here